IL5 and asthma: CP and OA were shown to significantly inhibit airway and lung inflammation, mucus secretion, lymphocytes, neutrophil and eosinophil infiltration, AHR, and inflammatory mediators such as IL-5, IL-13, CCR3, MUC5AC, and COX-2 in the mouse model of asthma.